http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018097426-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a768a99b1c52ee62e217dce090337c6d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfd88c28cdb4fe979a1711fa1cefb7c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63ee24df08e2794d673c0cc3816a6766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f269a05671e3204d9698db80fd01dccc
publicationDate 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018097426-A1
titleOfInvention Oral tablet composition comprising dexlansoprazole, oral tablet comprising same and method for manufacturing same
abstract The present invention relates to: an oral tablet composition comprising amorphous dexlansoprazole, mannitol having an average particle size of 100-400 µm, a disintegrating agent and a lubricant; an oral tablet comprising same; and a method for manufacturing same. The oral tablet composition, according to the present invention, exhibits excellent hardness, has a shortened disintegration time, and at the same time, may be used to provide an oral tablet having improved friability. In addition, according to the present invention, a dry direct compression method is used as the method for manufacturing the oral tablet, and thus an increase in production efficiency by simplifying the production process may be achieved.
priorityDate 2016-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014030328-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013111149-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012164233-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011189271-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012231073-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25203916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450364447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID69944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454668499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9578005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426147363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121950
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID69944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448178750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819

Total number of triples: 66.